CellFX System for the Treatment of Cutaneous Non-Genital Warts

Inclusion Criteria: * Subjects must be at least 21 and not older than 80 years of age * Subjects must be able to read and speak English or Spanish * Subjects must sign a written informed consent to participate in the study, prior to any study related procedures * Subject must have a minimum of two cutaneous non-genital warts, each not exceeding 10 x 10mm * Subject is willing to undergo all study-mandated procedures * Subject agrees to refrain from using all other wart removal products or treatments (topical medication including over-the-counter medications) during the study period Exclusion Criteria: * Subject has an implantable electronic medical device. (pacemaker, implantable cardioverter defibrillator, etc.) * Subject has cochlear implants * Subject has an active systemic infection or history of an infection in the designated treatment area within 90 days of enrollment * Subject has a history of and/or current tinnitus * Subject is known to be immune-compromised * Subject is taking a blood thinning medication (Antiplatelet, Anticoagulation, Factor Xa Inhibitor, etc.) * Subject has Type 1 Diabetes and is insulin dependent * Subject has a known allergy to Lidocaine or Lidocaine-like products * Subject is a member of a vulnerable population including individuals employed by the Sponsor, clinic site, or entity associated with the conduct of the study * Subject has a comorbidity or condition which may reduce compliance with this protocol, including follow-up visits * Subject is participating in another research study involving an investigational agent (pharmaceutical, biologic, or medical device)